This next table shows the highs and lows of yields and the Federal Funds Rate (FFR) since 2007. A Long-Term Look at the 10-Year Treasury Yield Here is a long-term view of the 10-year yield starting in 1965, well before the 1973 oil embargo that triggered the era of 'stagflation' (economic stagnation coupled with inflation) Inverted Yield Curve An inverted yield curve is when longer-term Treasury yields are lower than their shorter term counterparts. The next chart displays the latest 10-2 spread. Typically, ...

Core Viewpoint - Needham downgraded Amicus Therapeutics from Buy to Hold amid significant developments in the biotech sector, particularly following BioMarin Pharmaceutical's acquisition of Amicus valued at $4.8 billion [1][6]. Company Summary - Amicus Therapeutics is a biotechnology company focused on developing therapies for rare diseases [1]. - The company's stock price is currently at $14.21, reflecting a notable increase of 30.43% or $3.31, driven by investor interest related to the acquisition news [3][6]. - Amicus has a market capitalization of approximately $4.38 billion, with a trading volume of about 132.8 million shares [4]. Industry Summary - BioMarin Pharmaceutical's acquisition of Amicus is part of a broader trend of consolidation in the biotech industry, aimed at expanding capabilities and product offerings [2][5]. - The acquisition is expected to enhance BioMarin's portfolio by adding two rare disease drugs from Amicus, strengthening its market position and driving future growth [2][5].

I think last week quietly did something that markets don't do very often, and that is to improve visibility without requiring a heroic assumption. A cooling inflation environment, a labor market that isHi, I'm Yiannis. Spotting winners before they break out is what I do best.Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, with BSc and MSc degrees from U.K. business schools. Investment St ...

Altcoins are sick. The prescription? Buy. That’s what BitMEX co-founder Arthur Hayes advised investors to do in a Friday essay where he declared that “shitcoins are sickly” after the October 10 liquidation event that took out $19 billion. But with the Federal Reserve printing $40 billion a month through its new Reserve Management Purchases programme — which Hayes reckons mirrors quantitative easing and will shoot Bitcoin to $200,000 by March — conditions are improving. “It will take time for the altcoi ...

Market Sentiment - The market is experiencing fluctuations, with a recent uptick in AI-related trades noted as a positive sign [1] - The performance of Oracle is highlighted as significant, raising questions about consumer engagement and holiday season outcomes [2] Investment Themes - AI is expected to remain a strong investment theme, with a focus on capital expenditures from sectors beyond technology, such as industrials and financials [4] - The healthcare sector is also mentioned, with recent agreements on price cuts potentially serving as a tailwind for investments [4] Small Cap Performance - There is a favorable outlook for small-cap stocks, particularly in the first half of 2026, driven by economic growth, lower rates, and liquidity infusion around tax time [5] Interest Rates Outlook - Expectations indicate at least one more interest rate cut in the first quarter of the upcoming year, with a cautious approach to the Federal Reserve's actions in the latter half [6][7] Global Market Perspective - The U.S. economy shows meaningful strength, with optimism towards Japan and emerging markets (EM) becoming more attractive, particularly in the context of the AI trade [8][9] - Korea is identified as a potential opportunity within emerging markets, suggesting a diversified approach beyond just China [9][10]

Election of Directors – Electoral Quotient System The Company has been granted an exemption from the individual voting and majority voting requirements applicable to listed issuers under Toronto Stock Exchange policies, on grounds that compliance with such requirements would constitute a breach of Colombian laws and regulations which require the directors to be elected on the basis of a slate of nominees proposed for election pursuant to an electoral quotient system. For further information, please see the ...

NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Coupang, Inc. (NYSE: CPNG) between August 6, 2025 and December 16, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 17, 2026 in the securities class action first filed by the Firm. So what: If y ...

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Nexus Industrial REIT (“Nexus” or the "REIT") (TSX: NXR.UN) announced today the declaration of the January and February 2026 distributions. The REIT will make a cash distribution in the amount of $0.05333 per unit, representing $0.64 per unit on an annualized basis, payable February 13, 2026 to unitholders of record as of January 30, 2026. The REIT will also make a cash distribution in the amount of $0.05333 per unit, representing $0.64 per unit on an annualized ba ...

Core Insights - Paychex, Inc. reported an earnings per share (EPS) of $1.26, exceeding the estimated $1.23 and showing improvement from $1.14 in the same quarter last year [1][6] - The company's revenue for the quarter ending November 2025 was approximately $1.56 billion, surpassing the estimated $1.55 billion and increasing from $1.32 billion in the same period last year [2][6] - Despite rising expenses, Paychex raised its forecast for annual adjusted earnings growth, demonstrating resilience with a +1.61% earnings surprise this quarter [3] Financial Performance - Paychex has a price-to-earnings (P/E) ratio of approximately 25.44, indicating strong investor confidence [4][6] - The company maintains a low debt-to-equity ratio of 0.022, reflecting prudent financial management [4] - The enterprise value to sales ratio is around 6.51, and the enterprise value to operating cash flow ratio is approximately 17.18, suggesting effective cash generation from operations [5] Investment Metrics - Paychex offers an earnings yield of about 3.93%, providing a solid return on investment for shareholders [5] - The current ratio of approximately 1.27 indicates the company's ability to cover short-term liabilities with short-term assets, reinforcing financial stability [5]

 December 19, 2025 – TheNewswire - London, Ontario – Peloton Minerals Corporation (“PMC” or the “Company”) (CSE Symbol: PMC OTCQB; Symbol: PMCCF) has re-granted a total of 2,100,000 incentive stock options to directors of the Company to replace options that expired on December 18, 2025. The options are exercisable over five years at an exercise price of $0.115.  For further information please contact: Edward (Ted) Ellwood, MBAPresident & CEO        1-519-964-2836 Peloton Minerals Corporation is a reporting ...